相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Renal microvascular lesions in lupus nephritis
Ying Ding et al.
RENAL FAILURE (2020)
Role of the NLRP3 inflammasome in autoimmune diseases
Zhe Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
IL-6 promotes collagen-induced arthritis by activating the NLRP3 inflammasome through the cathepsin B/S100A9-mediated pathway
Hongyue Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells
Dayvia A. Russell et al.
LUPUS SCIENCE & MEDICINE (2020)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Erin Fahey et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pathogenesis and therapeutic interventions for ANCA-associated vasculitis
Daigo Nakazawa et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Performance of cytokine models in predicting SLE activity
Nopparat Ruchakorn et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Cutaneous vasculitis in systemic lupus erythematosus patients: potential key players and implications
T. A. Gheita et al.
LUPUS (2018)
NLRP3: A promising therapeutic target for autoimmune diseases
Hui-Hui Shen et al.
AUTOIMMUNITY REVIEWS (2018)
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
Rachel Mende et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anakinra Therapy for Non-cancer Inflammatory Diseases
Giulio Cavalli et al.
FRONTIERS IN PHARMACOLOGY (2018)
Prognostic significance of renal vascular pathology in lupus nephritis
J. M. Mejia-Vilet et al.
LUPUS (2017)
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes
Feng Yu et al.
NATURE REVIEWS NEPHROLOGY (2017)
Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis
Rong Fu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus
Christoffer T. Nielsen et al.
CLINICAL PROTEOMICS (2017)
The Cutaneous Spectrum of Lupus Erythematosus
Simone Ribero et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Anti-endothelial cell antibodies in vasculitis: A systematic review
Paul Legendre et al.
AUTOIMMUNITY REVIEWS (2017)
Vasculitis in the autoinflammatory diseases
Hagit Peleg et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
Pathogenesis of ANCA-associated vasculitis: An update
Pierre-Andre Jarrot et al.
AUTOIMMUNITY REVIEWS (2016)
Connective Tissue Disorder-Associated Vasculitis
Aman Sharma et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Systemic lupus erythematosus
Arvind Kaul et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The role of cytokines in the pathogenesis of cutaneous lupus erythematosus
E. S. Robinson et al.
CYTOKINE (2015)
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab
Alvise Berti et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Glycogen Synthase Kinase 3β Promotion of Renal Damage Through Activation of the NLRP3 Inflammasome in Lupus-Prone Mice
Jijun Zhao et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Autoantibodies in systemic vasculitis
Alexandre Wagner Silva de Souza
FRONTIERS IN IMMUNOLOGY (2015)
Association of Anti-Acidic Ribosomal Protein P0 and Anti-Galectin 3 Antibodies With the Development of Skin Lesions in Systemic Lupus Erythematosus
Zhen-rui Shi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Effect of Proinflammatory Cytokines (IL-6, TNF-alpha, and IL-1 beta) on Clinical Manifestations in Indian SLE Patients
Vinod Umare et al.
MEDIATORS OF INFLAMMATION (2014)
Pulmonary Manifestations of Systemic Lupus Erythematosus
Shikha Mittoo et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Vasculitis in Systemic Lupus Erythematosus
L. Barile-Fabris et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
P2X7 Blockade Attenuates Murine Lupus Nephritis by Inhibiting Activation of the NLRP3/ASC/Caspase 1 Pathway
Jijun Zhao et al.
ARTHRITIS AND RHEUMATISM (2013)
Efficacy and safety of canakinumab in urticarial vasculitis: An open-label study
Karoline Krause et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Hemorrhagic Shock Augments Nlrp3 Inflammasome Activation in the Lung through Impaired Pyrin Induction
Peng Xu et al.
JOURNAL OF IMMUNOLOGY (2013)
Endothelial dysfunction in rheumatic autoimmune diseases
Giuseppe Murdaca et al.
ATHEROSCLEROSIS (2012)
Cutting Edge: IL-6 Is a Marker of Inflammation with No Direct Role in Inflammasome-Mediated Mouse Models
Matthew D. McGeough et al.
JOURNAL OF IMMUNOLOGY (2012)
IL-10 Is a Negative Regulatory Factor of CAWS-Vasculitis in CBA/J Mice as Assessed by Comparison with Bruton's Tyrosine Kinase-Deficient CBA/N Mice
Noriko N. Miura et al.
JOURNAL OF IMMUNOLOGY (2009)
The role of inflammatory cytokines in endothelial dysfunction
Cuihua Zhang
BASIC RESEARCH IN CARDIOLOGY (2008)
Evolving functions of endothelial cells in inflammation
Jordan S. Pober et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra
C. Botsios et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
Vasculitis in systemic lupus erythematosus -: Prevalence and clinical characteristics in 670 patients
M Ramos-Casals et al.
MEDICINE (2006)
Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1 beta
S Yung et al.
KIDNEY INTERNATIONAL (2006)
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
分享论文
